Company Overview
Snapshot
Founded in June 2023 by Or Litman and Lior Saban, 2C3D operates with 1–10 employees. The company has secured $40K in total funding across one funding round. In October 2023, 2C3D received a grant from the Israel Innovation Authority.
Business overview
2C3D is a Health Tech & Life Sciences company focused on advancing melanoma cancer treatment. The company integrates state-of-the-art diagnostic methods and digital pathology to achieve complete eradication of melanoma through a single surgical procedure. By studying the functional properties of melanoma, 2C3D aims to enhance treatment outcomes and expand these methods to other types of skin tumors, serving the healthcare and medical devices industries with a commitment to improving patient lives.
Log in to access full profile ›Company Intelligence Q&A
- When was 2C3D founded?
- 2C3D was founded in June 2023 by Or Litman and Lior Saban.
- What is 2C3D's primary focus?
- 2C3D is focused on advancing melanoma cancer treatment by integrating state-of-the-art diagnostic methods and digital pathology to achieve complete eradication of melanoma through a single surgical procedure.
- How many employees does 2C3D have?
- 2C3D operates with 1–10 employees.